Gordon J - Search Results

1

Sex-by-formulation interaction in bioequivalence trials with transdermal patches.

González-Rojano E, Marcotegui J, Morales-Alcelay S, Álvarez C, Gordon J, Abad-Santos F, García-Arieta A. González-Rojano E, et al. Among authors: gordon j. Eur J Clin Pharmacol. 2019 Jun;75(6):801-808. doi: 10.1007/s00228-019-02632-1. Epub 2019 Feb 6. Eur J Clin Pharmacol. 2019. PMID: 30725220 Review.

2

Investigation on the possibility of biowaivers for ibuprofen.

Alvarez C, Núñez I, Torrado JJ, Gordon J, Potthast H, García-Arieta A. Alvarez C, et al. Among authors: gordon j. J Pharm Sci. 2011 Jun;100(6):2343-9. doi: 10.1002/jps.22472. Epub 2011 Jan 14. J Pharm Sci. 2011. PMID: 21491448 Clinical Trial.

3

Bioequivalence requirements in the European Union: critical discussion.

García-Arieta A, Gordon J. García-Arieta A, et al. Among authors: gordon j. AAPS J. 2012 Dec;14(4):738-48. doi: 10.1208/s12248-012-9382-1. Epub 2012 Jul 24. AAPS J. 2012. PMID: 22826032 Free PMC article. Review.

4

Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO.

Gwaza L, Gordon J, Welink J, Potthast H, Hansson H, Stahl M, García-Arieta A. Gwaza L, et al. Among authors: gordon j. Eur J Clin Pharmacol. 2012 Dec;68(12):1611-8. doi: 10.1007/s00228-012-1396-1. Epub 2012 Sep 21. Eur J Clin Pharmacol. 2012. PMID: 23011014 Clinical Trial.

5

Adjusted indirect treatment comparison of the bioavailability of WHO-prequalified first-line generic antituberculosis medicines.

Gwaza L, Gordon J, Welink J, Potthast H, Leufkens H, Stahl M, García-Arieta A. Gwaza L, et al. Among authors: gordon j. Clin Pharmacol Ther. 2014 Nov;96(5):580-8. doi: 10.1038/clpt.2014.144. Epub 2014 Jul 2. Clin Pharmacol Ther. 2014. PMID: 24987832

6

On the BCS biowaivers of orally disintegrating tablets.

García-Arieta A, Gordon J. García-Arieta A, et al. Among authors: gordon j. Eur J Pharm Sci. 2015 Jan 23;66:107-8. doi: 10.1016/j.ejps.2014.10.009. Epub 2014 Oct 18. Eur J Pharm Sci. 2015. PMID: 25459529

7

On the Biopharmaceutics Classification System Biowaiver of Ibuprofen.

García-Arieta A, Gordon J, Potthast H. García-Arieta A, et al. Among authors: gordon j. J Pharm Sci. 2015 Aug;104(8):2429-32. doi: 10.1002/jps.24519. Epub 2015 Jun 2. J Pharm Sci. 2015. PMID: 26036644 No abstract available.

8

Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons.

Gwaza L, Gordon J, Potthast H, Welink J, Leufkens H, Stahl M, García-Arieta A. Gwaza L, et al. Among authors: gordon j. Eur J Clin Pharmacol. 2015 Sep;71(9):1083-9. doi: 10.1007/s00228-015-1889-9. Epub 2015 Jun 24. Eur J Clin Pharmacol. 2015. PMID: 26105964

9

Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets.

Garcia-Arieta A, Gordon J, Gwaza L, Mangas-Sanjuan V, Álvarez C, Torrado JJ. Garcia-Arieta A, et al. Among authors: gordon j. Mol Pharm. 2015 Sep 8;12(9):3194-201. doi: 10.1021/acs.molpharmaceut.5b00131. Epub 2015 Aug 10. Mol Pharm. 2015. PMID: 26237401

10

On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs.

García-Arieta A, Gordon J, Potthast H. García-Arieta A, et al. Among authors: gordon j. J Pharm Sci. 2016 Apr;105(4):1353-4. doi: 10.1016/j.xphs.2016.01.005. J Pharm Sci. 2016. PMID: 27019955 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,872 results

Search Page